Papers
1
Total Citations
5
H-Index
1
About
Tingting Peng is a leading researcher in advanced drug delivery systems, with a primary focus on microneedle technology for overcoming biological barriers. Her work centers on the development of innovative platforms for biomacromolecular delivery, targeting major diseases including tumors, infections, cardiovascular conditions, metabolic disorders, and autoimmune diseases. Peng’s most notable contribution, her 2025 paper “Microneedle Technology for Overcoming Biological Barriers: Advancing Biomacromolecular Delivery and Therapeutic Applications in Major Diseases,” has already garnered 5 citations, reflecting its immediate impact in the field. She has been instrumental in addressing the critical challenge of administering biomacromolecules—such as proteins and nucleic acids—which traditionally rely on professional medical supervision. By engineering microneedle-based systems that enable minimally invasive, patient-friendly delivery, Peng is paving the way for more accessible and effective therapies. Her work holds particular promise for transforming treatment paradigms in oncology and chronic disease management, reducing dependence on frequent clinical visits. Peng’s research continues to bridge the gap between laboratory innovation and clinical translation, positioning her as an emerging leader in pharmaceutical engineering and translational medicine.
Research Focus
Key Achievements
Top Papers
- 1